ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 35 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $827,470 | +16.9% | 603,993 | +16.9% | 0.01% | +25.0% |
| Q2 2023 | $707,845 | -41.9% | 516,675 | 0.0% | 0.01% | -52.9% |
| Q1 2023 | $1,219,353 | +3.5% | 516,675 | 0.0% | 0.02% | +6.2% |
| Q4 2022 | $1,178,019 | -17.4% | 516,675 | 0.0% | 0.02% | -20.0% |
| Q3 2022 | $1,426,000 | +13.1% | 516,675 | 0.0% | 0.02% | +5.3% |
| Q2 2022 | $1,261,000 | -52.5% | 516,675 | -23.2% | 0.02% | -55.8% |
| Q1 2022 | $2,652,000 | -23.0% | 673,138 | -13.9% | 0.04% | -12.2% |
| Q4 2021 | $3,446,000 | -28.6% | 781,376 | 0.0% | 0.05% | -38.0% |
| Q3 2021 | $4,829,000 | -28.8% | 781,376 | -8.9% | 0.08% | -37.3% |
| Q2 2021 | $6,782,000 | -28.9% | 857,445 | -3.8% | 0.13% | -40.3% |
| Q1 2021 | $9,534,000 | – | 891,055 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |